Silence Therapeutics Unveils Breakthrough Clinical Programs for SLN360 and SLN124
Silence Therapeutics plc, Nasdaq: SLN (“Silence” or “the Company”), a pioneering biotechnology company dedicated to improving lives by developing precision-engineered medicines to silence diseases, provided … Read more